Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 220

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 220
---
 Restricted Stock Awards Granted On February 11, 2025, 58,568Restricted Stock Awards, were granted to employees and the Board of Directors which resulted in a fair value of $ 0.2million of stock-based compensation expense based on the Company’s stock price on the date of grant. The grants were granted from shares of the 2021 Plan and either vest 100% on the date of grant or vest 50% on the date of grant, with 50% vesting on the vest oneyear thereafter. Regaining Nasdaq Compliance As previously reported on October 16, 2024, the Company received a letter from Nasdaq notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) by failing to maintain a minimum bid price for its common stock of at least $ 1.00per share for 30consecutive business days. The Company had until February 14, 2025, to regain compliance by having a minimum closing bid price of at least $ 1.00per share for at least 10consecutive business days. On February 19, 2025 the Company received a formal notice from Nasdaq stating that the Company’s common stock will continue to be listed and traded on Nasdaq, due to the Company having regained compliance with the minimum bid price requirement, and all applicable listing standards. Class F Common Stock Warrant Exercises As of March 3, 2025, the Company received alternative cashless exercise notices for 3,064,040Class F Common Stock Warrants to purchase 383,006shares of common stock issued in connection with the Class E Warrant Inducement. F-27 REVELATION BIOSCIENCES, INC. Condensed Consolidated Balance Sheets (Unaudited)

|                                                                                                                                                                 |     |   |   March 31, 
        2025 |   |     |   | December 31, 
         2024 |   |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:--|------------:|:--|:----|:--|-------------:|:--|
| ASSETS                                                                                                                                                          |     |   |             |   |     |   |              |   |
| Current assets:                                                                                                                                                 |     |   |             |   |     |   |              |   |
| Cash and cash equivalents                                                                                                                                       |     | $ |   3,704,611 |   |     | $ |    6,499,018 |   |
|